These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12369742)

  • 1. The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity.
    Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
    J Physiol Pharmacol; 2002 Sep; 53(3):463-75. PubMed ID: 12369742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat.
    Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
    Pol J Pharmacol; 2002; 54(2):143-50. PubMed ID: 12139111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on plasma paraoxonase 1 activity in the rat.
    Bełtowski J; Wójcicka G; Jamroz A
    Pol J Pharmacol; 2002; 54(6):661-71. PubMed ID: 12866722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
    Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KK-Ay mice.
    Kuwabara K; Murakami K; Todo M; Aoki T; Asaki T; Murai M; Yano J
    J Pharmacol Exp Ther; 2004 Jun; 309(3):970-7. PubMed ID: 14982965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fenofibrate on lipid metabolism in adipose tissue of rats.
    Ferreira AV; Parreira GG; Green A; Botion LM
    Metabolism; 2006 Jun; 55(6):731-5. PubMed ID: 16713430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
    Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
    Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fenofibrate on serum paraoxonase activity and inflammatory markers in patients with combined hyperlipidemia.
    Yesilbursa D; Serdar A; Saltan Y; Serdar Z; Heper Y; Guclu S; Cordan J
    Kardiol Pol; 2005 Jun; 62(6):526-30. PubMed ID: 16123850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: a comparison with fenofibrate.
    Harnafi H; Bouanani Nel H; Aziz M; Serghini Caid H; Ghalim N; Amrani S
    J Ethnopharmacol; 2007 Jan; 109(1):156-60. PubMed ID: 17092671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum paraoxonase activity, total antioxidant potential and lipid peroxidation products in children with bronchial asthma exacerbation].
    Górnicka G; Bełtowski J; Wójcicka G; Jamroz A
    Wiad Lek; 2002; 55(5-6):257-63. PubMed ID: 12235690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
    Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
    Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected markers of oxidative stress in rats with active Heymann nephritis.
    Koroliczuk A; Chibowski D; Bełtowski J; Wójcicka G
    Med Sci Monit; 2001; 7(3):369-76. PubMed ID: 11386011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
    Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
    Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers.
    Wagner JA; Larson PJ; Weiss S; Miller JL; Doebber TW; Wu MS; Moller DE; Gottesdiener KM
    J Clin Pharmacol; 2005 May; 45(5):504-13. PubMed ID: 15831773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.